Correlation Between Pharvaris and Olema Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Pharvaris and Olema Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharvaris and Olema Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pharvaris BV and Olema Pharmaceuticals, you can compare the effects of market volatilities on Pharvaris and Olema Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharvaris with a short position of Olema Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharvaris and Olema Pharmaceuticals.
Diversification Opportunities for Pharvaris and Olema Pharmaceuticals
-0.1 | Correlation Coefficient |
Good diversification
The 3 months correlation between Pharvaris and Olema is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding Pharvaris BV and Olema Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Olema Pharmaceuticals and Pharvaris is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharvaris BV are associated (or correlated) with Olema Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Olema Pharmaceuticals has no effect on the direction of Pharvaris i.e., Pharvaris and Olema Pharmaceuticals go up and down completely randomly.
Pair Corralation between Pharvaris and Olema Pharmaceuticals
Given the investment horizon of 90 days Pharvaris BV is expected to generate 0.83 times more return on investment than Olema Pharmaceuticals. However, Pharvaris BV is 1.21 times less risky than Olema Pharmaceuticals. It trades about -0.08 of its potential returns per unit of risk. Olema Pharmaceuticals is currently generating about -0.08 per unit of risk. If you would invest 2,480 in Pharvaris BV on August 31, 2024 and sell it today you would lose (244.00) from holding Pharvaris BV or give up 9.84% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 95.65% |
| Values | Daily Returns |
Pharvaris BV vs. Olema Pharmaceuticals
Performance |
| Timeline |
| Pharvaris BV |
| Olema Pharmaceuticals |
Pharvaris and Olema Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pharvaris and Olema Pharmaceuticals
The main advantage of trading using opposite Pharvaris and Olema Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharvaris position performs unexpectedly, Olema Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Olema Pharmaceuticals will offset losses from the drop in Olema Pharmaceuticals' long position.| Pharvaris vs. Cue Biopharma | Pharvaris vs. Eliem Therapeutics | Pharvaris vs. Inhibrx | Pharvaris vs. Molecular Partners AG |
| Olema Pharmaceuticals vs. Sana Biotechnology | Olema Pharmaceuticals vs. Cullinan Oncology LLC | Olema Pharmaceuticals vs. Zentalis Pharmaceuticals Llc | Olema Pharmaceuticals vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |